Advertisement

Characteristics, prevalence and sources of stress in individuals who discontinue assisted reproductive technology treatments: a systematic review

Published:February 01, 2023DOI:https://doi.org/10.1016/j.rbmo.2023.01.020

      Abstract

      By considering the reasons behind discontinuing assisted reproductive technology (ART) treatment, several studies have indicated that ‘stress’ is an important issue, but the prevalence of stressors and stress responses, either acute or chronic, remains unclear. In this systematic review, we evaluated the characteristics, prevalence and causes of what was perceived and reported as ‘stress’ by couples who discontinued ART treatment. Electronic databases were systematically searched, and studies were considered eligible if they evaluated stress as a possible reason for ART discontinuation. Twelve studies were included, with 15,264 participants from eight countries. In all studies, ‘stress’ was assessed through generic questionnaires or medical records, not by validated stress questionnaires or biomarkers. The prevalence of ‘stress’ ranged from 11–53%. When the results were pooled, ‘stress’ was cited as a reason for ART discontinuation by 775 out of 2507 participants (30.9%). Clinical factors associated with worse prognosis, physical discomfort due to treatment procedures, family demands, time pressure and economic burden were identified as sources of ‘stress’ that contributed to ART discontinuation. Precisely knowing the characteristics of the stress associated with infertility is essential to devise preventive or supportive interventions to help patients to cope and endure the treatments. Further studies are necessary to investigate whether the mitigation of stress factors can reduce ART discontinuation rates.

      KEYWORDS

      Introduction

      Globally, it is estimated that millions of individuals suffer with infertility (
      • Cox C.M.
      • Thoma M.E.
      • Tchangalova N.
      • Mburu G.
      • Bornstein M.J.
      • Johnson C.L.
      • Kiarie J.
      Infertility prevalence and the methods of estimation from 1990 to 2021: a systematic review and meta-analysis.
      ). Assisted reproductive technology (ART) offers new hope for infertile persons and couples to become biological parents, particularly when oocytes are collected before ovarian ageing (
      • Chambers G.M.
      • Dyer S.
      • Zegers-Hochschild F.
      • de Mouzon J.
      • Ishihara O.
      • Banker M.
      • Mansour R.
      • Kupka M.S.
      • Adamson G.D.
      International Committee for Monitoring Assisted Reproductive Technologies world report: assisted reproductive technology, 2014dagger.
      ). As much as 60% of these individuals, however, forego proposed treatments before achieving pregnancy (
      • Schröder A.K.
      • Katalinic A.
      • Diedrich K.
      • Ludwig M.
      Cumulative pregnancy rates and drop-out rates in a German IVF programme: 4102 cycles in 2130 patients.
      ;
      • Miller L.M.
      • Wallace G.
      • Birdsall M.A.
      • Hammond E.R.
      • Peek J.C.
      Dropout rate and cumulative birth outcomes in couples undergoing in vitro fertilization within a funded and actively managed system of care in New Zealand.
      ). Dropout is an important failure cause in ART, as pursuing several treatment cycles can triple the chance of a live birth compared with a single cycle (
      • Lande Y.
      • Seidman D.S.
      • Maman E.
      • Baum M.
      • Hourvitz A.
      Why do couples discontinue unlimited free IVF treatments?.
      ;
      • Leijdekkers J.A.
      • Eijkemans M.J.C.
      • van Tilborg T.C.
      • Oudshoorn S.C.
      • van Golde R.J.T.
      • Hoek A.
      • Lambalk C.B.
      • de Bruin J.P.
      • Fleischer K.
      • Mochtar M.H.
      • Kuchenbecker W.K.H.
      • Laven J.S.E.
      • Mol B.W.J.
      • Torrance H.L.
      • Broekmans F.J.M.
      Cumulative live birth rates in low-prognosis women.
      ;
      • Gu F.
      • Ruan S.
      • Luo C.
      • Huang Y.
      • Luo L.
      • Xu Y.
      • Zhou C.
      Can repeat IVF/ICSI cycles compensate for the natural decline in fertility with age? an estimate of cumulative live birth rates over multiple IVF/ICSI cycles in Chinese advanced-aged population.
      ;
      • Miller L.M.
      • Wallace G.
      • Birdsall M.A.
      • Hammond E.R.
      • Peek J.C.
      Dropout rate and cumulative birth outcomes in couples undergoing in vitro fertilization within a funded and actively managed system of care in New Zealand.
      ).
      By considering the reasons behind ART treatment discontinuation, several studies have indicated that ‘stress’ is an important cause (
      • Rooney K.L.
      • Domar A.D.
      The relationship between stress and infertility.
      ;
      • Galhardo A.
      • Alves J.
      • Moura-Ramos M.
      • Cunha M.
      Infertility-related stress and depressive symptoms - the role of experiential avoidance: a cross-sectional study.
      ;
      • Geisler M.
      • Meaney S.
      • Waterstone J.
      • O'Donoghue K.
      Stress and the impact on the outcome of medically assisted reproduction.
      ). Physiologically, stress is defined as an exacerbated, energy-expending response to an environmental event, generated by a threat or by an anticipated threat to organism integrity, whether real or perceived, psychological or physical (
      • Selye H.
      A syndrome produced by diverse nocuous agents. 1936.
      ). This environmental event is commonly called a stressor or stress factor, whereas reactions to factors are termed stress responses (Figure 1). This response is quite complex and induces neurological and metabolic alterations, with central and peripheral repercussions. The stress response starts in the hypothalamus and the brainstem, where specialized neurones produce corticotrophin-releasing hormone and arginine-vasopressin, as well as the locus coeruleus and other central areas that release noradrenaline. The response reaches peripheral organs by endocrine (adrenocorticotropic hormone) and neural (sympathetic) pathways (
      • Tsigos C.
      • Kyrou I.
      • Kassi E.
      • Chrousos G.P.
      Stress: Endocrine Physiology and Pathophysiology.
      ). According to its duration, intensity and perception, an individual response can vary widely (
      • Reis F.M.
      • Coutinho L.M.
      • Vannuccini S.
      • Luisi S.
      • Petraglia F.
      Is Stress a Cause or a Consequence of Endometriosis?.
      ).
      Figure 1:
      Figure 1Left: examples of stressors (stress factors) cited by women and couples who discontinued assisted reproductive technology treatments; centre: the stress response driven by the hypothalamus–pituitary–adrenal axis; right: acute and chronic stress symptoms that can be assessed through objective questionnaires (adapted from
      • Tsigos C.
      • Kyrou I.
      • Kassi E.
      • Chrousos G.P.
      Stress: Endocrine Physiology and Pathophysiology.
      and
      • Nery S.F.
      • Paiva S.P.C.
      • Vieira É L.
      • Barbosa A.B.
      • Sant'Anna E.M.
      • Casalechi M.
      • Dela Cruz C.
      • Teixeira A.L.
      • Reis F.M.
      Mindfulness-based program for stress reduction in infertile women: Randomized controlled trial.
      ).
      An acute stress factor, such as receiving an infertility diagnosis, activates the sympathetic nervous system and the hypothalamus–pituitary–adrenal axis, which normally prepares individuals for adverse situations (
      • Stefanaki C.
      • Pervanidou P.
      • Boschiero D.
      • Chrousos G.P.
      Chronic stress and body composition disorders: implications for health and disease.
      ). When situations are prolonged, such as years of unsuccessful fertility treatment, an inability to cope may produce a chronic stress state that triggers a catabolic process and causes cell and organ damage (
      • Lazarus R.
      • Folkman S.
      Stress, appraisal, and coping.
      ;
      • Smeenk J.M.
      • Verhaak C.M.
      • Stolwijk A.M.
      • Kremer J.A.
      • Braat D.D.
      Reasons for dropout in an in vitro fertilization/intracytoplasmic sperm injection program.
      ;
      • Walschaerts M.
      • Bujan L.
      • Parinaud J.
      • Mieusset R.
      • Thonneau P.
      Treatment discontinuation in couples consulting for male infertility after failing to conceive.
      ;
      • Lande Y.
      • Seidman D.S.
      • Maman E.
      • Baum M.
      • Hourvitz A.
      Why do couples discontinue unlimited free IVF treatments?.
      ;
      • Reis F.M.
      • Coutinho L.M.
      • Vannuccini S.
      • Luisi S.
      • Petraglia F.
      Is Stress a Cause or a Consequence of Endometriosis?.
      ). This state can be distinguished from other psychological phenomena, like anxiety and depression. This is because chronic stress produces a predominantly somatic condition with marked endocrine and autonomic responses (
      • Lindeberg S.I.
      • Ostergren P.O.
      • Lindbladh E.
      Exhaustion is differentiable from depression and anxiety: evidence provided by the SF-36 vitality scale.
      ;
      • Stefanaki C.
      • Pervanidou P.
      • Boschiero D.
      • Chrousos G.P.
      Chronic stress and body composition disorders: implications for health and disease.
      ).
      If stress is an important reason for ART discontinuation, strategies reversing this process can incorporate improved coping mechanisms (
      • Verkuijlen J.
      • Verhaak C.
      • Nelen W.L.
      • Wilkinson J.
      • Farquhar C.
      Psychological and educational interventions for subfertile men and women.
      ;
      • Sant'Anna E.M.
      • Paiva S.P.C.
      • Santos R.P.
      • Rodrigues A.M.S.
      • Davis N.A.
      • Nery S.F.
      • Maia F.P.
      • Ferreira A.V.M.
      • Reis F.M.
      Mindfulness-based program to support lifestyle modification and weight loss in infertile women: randomized controlled trial.
      ;
      • Rahimi R.
      • Hasanpour S.
      • Mirghafourvand M.
      • Esmaeilpour K.
      Effect of Hope-oriented group counseling on mental health of infertile women with failed IVF cycles: a randomized controlled trial.
      ) and mitigation of the main stressors. The assessment of chronic stress, however, should ideally include objective scales of physical symptoms and measurement of biomarkers of the stress response (
      • Tsigos C.
      • Kyrou I.
      • Kassi E.
      • Chrousos G.P.
      Stress: Endocrine Physiology and Pathophysiology.
      ;
      • Nery S.F.
      • Paiva S.P.C.
      • Vieira É L.
      • Barbosa A.B.
      • Sant'Anna E.M.
      • Casalechi M.
      • Dela Cruz C.
      • Teixeira A.L.
      • Reis F.M.
      Mindfulness-based program for stress reduction in infertile women: Randomized controlled trial.
      ). Without knowing precisely what people who discontinue ART mean by ‘stress’, it is difficult to devise preventive or supportive interventions to help them to cope and endure the treatments. In this systematic review, we evaluated the characteristics, prevalence and causes of what was perceived and reported as ‘stress’ by couples who discontinued ART treatment.

      Materials and methods

      This study adhered to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines (
      • Page M.J.
      • McKenzie J.E.
      • Bossuyt P.M.
      • Boutron I.
      • Hoffmann T.C.
      • Mulrow C.D.
      • Shamseer L.
      • Tetzlaff J.M.
      • Akl E.A.
      • Brennan S.E.
      • Chou R.
      • Glanville J.
      • Grimshaw J.M.
      • Hrobjartsson A.
      • Lalu M.M.
      • Li T.
      • Loder E.W.
      • Mayo-Wilson E.
      • McDonald S.
      • McGuinness L.A.
      • Stewart L.A.
      • Thomas J.
      • Tricco A.C.
      • Welch V.A.
      • Whiting P.
      • Moher D.
      The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
      ) and was registered in the International Prospective Register of Systematic Reviews database (PROSPERO, reference CRD42020210932). The electronic bibliographic search was conducted using the databases PubMed/MEDLINE and Scopus. The search terms used were as follows: (‘ART’ OR ‘in-vitro fertilization’ OR ‘IVF’) AND stress NOT oxidative AND (dropout OR abandon OR discontinuation OR interruption). A comprehensive examination of reference sections in articles was also carried out to identify relevant manuscripts.
      The types of study eligible for inclusion were cohort, case-control, cross-sectional and case series. Additional inclusion criteria were as follows: individuals undergoing ART; discontinuation of ART treatment as an outcome; ‘stress’ as a cause of ART discontinuation; and publication in English. Exclusion criteria were as follows: non-human studies, review articles, case reports and full-text unavailability.
      Two research qualified reviewers (ES and SNF) independently read titles and abstracts of retrieved articles using a predefined search strategy and applied study criteria. Selected full texts were read by the same authors and then independently by two other authors (LCT and MC), using the same pre-established criteria. Any disagreements regarding article inclusion or exclusion were discussed until a consensus was reached. Then, data were extracted from selected studies independently by two reviewers. Data extraction included study design and type of questionnaire, participant numbers and characteristics, definition of ART discontinuation, reasons for discontinuing treatment and stress measure.
      The methodological quality of selected studies was assessed by two reviewers according to Newcastle–Ottawa Scale (NOS) criteria for case-control, cohort and cross-sectional studies. This scale consisted of three criteria: selection of participants; comparability of study groups; and verification of exposure (for case-control studies) or outcome of interest (for cohort and cross-sectional studies). The score was measured using a star system in which each study could receive 0–9 stars, with a maximum of four stars for the selection category, two for comparability and three for outcome or exposure. The score, or number of stars, was converted to the Agency for Health Care Research and Quality standard, which permitted study classification as poor, fair or good quality (
      • Shamsrizi P.
      • Gladstone B.P.
      • Carrara E.
      • Luise D.
      • Cona A.
      • Bovo C.
      • Tacconelli E.
      Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis.
      ).

      Results

      Description of studies

      Database and manual searches returned 109 non-duplicated articles, of which 97 did not meet inclusion criteria or were excluded for several reasons (Figure 2). Finally, 12 articles were selected for this review (
      • Mao K.
      • Wood C.
      Barriers to treatment of infertility by in-vitro fertilization and embryo transfer.
      ;
      • Goldfarb J.
      • Austin C.
      • Lisbona H.
      • Loret de Mola R.
      • Peskin B.
      • Stewart S.
      Factors influencing patients' decision not to repeat IVF.
      ;
      • Rajkhowa M.
      • McConnell A.
      • Thomas G.E.
      Reasons for discontinuation of IVF treatment: a questionnaire study.
      ;
      • Brandes M.
      • van der Steen J.O.
      • Bokdam S.B.
      • Hamilton C.J.
      • de Bruin J.P.
      • Nelen W.L.
      • Kremer J.A.
      When and why do subfertile couples discontinue their fertility care? A longitudinal cohort study in a secondary care subfertility population.
      ;
      • Moini A.
      • Salehizadeh S.
      • Moosavi F.
      • Kiani K.
      • Khafri S.
      Discontinuation decision in assisted reproductive techniques.
      ;
      • Domar A.D.
      • Smith K.
      • Conboy L.
      • Iannone M.
      • Alper M.
      A prospective investigation into the reasons why insured United States patients drop out of in vitro fertilization treatment.
      ;
      • McDowell S.
      • Murray A.
      Barriers to continuing in vitro fertilisation–why do patients exit fertility treatment?.
      ;
      • Khalili M.A.
      • Kahraman S.
      • Ugur M.G.
      • Agha-Rahimi A.
      • Tabibnejad N.
      Follow up of infertile patients after failed ART cycles: a preliminary report from Iran and Turkey.
      ;
      • Walschaerts M.
      • Bujan L.
      • Parinaud J.
      • Mieusset R.
      • Thonneau P.
      Treatment discontinuation in couples consulting for male infertility after failing to conceive.
      ;
      • Troude P.
      • Guibert J.
      • Bouyer J.
      • de La Rochebrochard E.
      Medical factors associated with early IVF discontinuation.
      ;
      • Domar A.D.
      • Rooney K.
      • Hacker M.R.
      • Sakkas D.
      • Dodge L.E.
      Burden of care is the primary reason why insured women terminate in vitro fertilization treatment.
      ;
      • Miller L.M.
      • Wallace G.
      • Birdsall M.A.
      • Hammond E.R.
      • Peek J.C.
      Dropout rate and cumulative birth outcomes in couples undergoing in vitro fertilization within a funded and actively managed system of care in New Zealand.
      ) (Figure 2).
      Figure 2:
      Figure 2Decision flowchart for study selection according to PRISMA 2020 guidelines (
      • Page M.J.
      • McKenzie J.E.
      • Bossuyt P.M.
      • Boutron I.
      • Hoffmann T.C.
      • Mulrow C.D.
      • Shamseer L.
      • Tetzlaff J.M.
      • Akl E.A.
      • Brennan S.E.
      • Chou R.
      • Glanville J.
      • Grimshaw J.M.
      • Hrobjartsson A.
      • Lalu M.M.
      • Li T.
      • Loder E.W.
      • Mayo-Wilson E.
      • McDonald S.
      • McGuinness L.A.
      • Stewart L.A.
      • Thomas J.
      • Tricco A.C.
      • Welch V.A.
      • Whiting P.
      • Moher D.
      The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
      ).
      Selected studies evaluated 15,264 participants from eight countries. The average age of women was 34 years, mean infertility duration was 5.7 years, and mean number of treatment cycles for each couple was 2.1. Of the 12 articles, eight were cohort studies (seven were retrospective), one was a case-control study and three were cross-sectional studies (Table 1). For inclusion criteria, four studies (
      • Mao K.
      • Wood C.
      Barriers to treatment of infertility by in-vitro fertilization and embryo transfer.
      ;
      • Goldfarb J.
      • Austin C.
      • Lisbona H.
      • Loret de Mola R.
      • Peskin B.
      • Stewart S.
      Factors influencing patients' decision not to repeat IVF.
      ;
      • Domar A.D.
      • Smith K.
      • Conboy L.
      • Iannone M.
      • Alper M.
      A prospective investigation into the reasons why insured United States patients drop out of in vitro fertilization treatment.
      ;
      • Troude P.
      • Guibert J.
      • Bouyer J.
      • de La Rochebrochard E.
      Medical factors associated with early IVF discontinuation.
      ) required that participants were starting their first ART cycle, one included only individuals with primary infertility (
      • Moini A.
      • Salehizadeh S.
      • Moosavi F.
      • Kiani K.
      • Khafri S.
      Discontinuation decision in assisted reproductive techniques.
      ) and another study included only cases of male factor infertility (
      • Walschaerts M.
      • Bujan L.
      • Parinaud J.
      • Mieusset R.
      • Thonneau P.
      Treatment discontinuation in couples consulting for male infertility after failing to conceive.
      ). Three studies (
      • Khalili M.A.
      • Kahraman S.
      • Ugur M.G.
      • Agha-Rahimi A.
      • Tabibnejad N.
      Follow up of infertile patients after failed ART cycles: a preliminary report from Iran and Turkey.
      ;
      • Troude P.
      • Guibert J.
      • Bouyer J.
      • de La Rochebrochard E.
      Medical factors associated with early IVF discontinuation.
      ;
      • Miller L.M.
      • Wallace G.
      • Birdsall M.A.
      • Hammond E.R.
      • Peek J.C.
      Dropout rate and cumulative birth outcomes in couples undergoing in vitro fertilization within a funded and actively managed system of care in New Zealand.
      ) were multicentric.
      TABLE 1CHARACTERISTICS OF THE INCLUDED STUDIES
      Author, yearCountryDesignParticipantsFemale age (years, mean)Infertility (years, mean)ART cyclesInsured ARTType of questionnaireDefinition of Discontinuation
      • Mao K.
      • Wood C.
      Barriers to treatment of infertility by in-vitro fertilization and embryo transfer.
      AustraliaCase-controlCouples undergoing the first cycle of IVF.369.04NoMultiple choiceInterrupt ART after the first cycle.
      • Goldfarb J.
      • Austin C.
      • Lisbona H.
      • Loret de Mola R.
      • Peskin B.
      • Stewart S.
      Factors influencing patients' decision not to repeat IVF.
      USARetrospective cohortWomen undergoing the first cycle of IVF.346.91NoLikert-type scale with 5 stagesInterrupt ART after the first cycle.
      • Rajkhowa M.
      • McConnell A.
      • Thomas G.E.
      Reasons for discontinuation of IVF treatment: a questionnaire study.
      ScotlandRetrospective cohortCouples undergoing ART.3710.0NAYesMultiple choiceDiscontinue ART before completing two or three cycles in 6 years.
      • Brandes M.
      • van der Steen J.O.
      • Bokdam S.B.
      • Hamilton C.J.
      • de Bruin J.P.
      • Nelen W.L.
      • Kremer J.A.
      When and why do subfertile couples discontinue their fertility care? A longitudinal cohort study in a secondary care subfertility population.
      HollandRetrospective cohortCouples undergoing ART.342.03YesOpenStop ART up to the time of data analysis.
      • Moini A.
      • Salehizadeh S.
      • Moosavi F.
      • Kiani K.
      • Khafri S.
      Discontinuation decision in assisted reproductive techniques.
      IranCross-sectionalCouples with primary infertility.34NA3NoOpenInterrupt ART after the third cycle.
      • Domar A.D.
      • Smith K.
      • Conboy L.
      • Iannone M.
      • Alper M.
      A prospective investigation into the reasons why insured United States patients drop out of in vitro fertilization treatment.
      USAProspective cohortWomen undergoing the first cycle of IVF.363.82YesMultiple choiceDiscontinue ART before completing the three cycles covered by insurance.
      • McDowell S.
      • Murray A.
      Barriers to continuing in vitro fertilisation–why do patients exit fertility treatment?.
      New ZealandRetrospective cohortCouples undergoing IVF treatment.NANA1YesLikert-type scale with 5 statesInterrupt ART after the first cycle.
      • Khalili M.A.
      • Kahraman S.
      • Ugur M.G.
      • Agha-Rahimi A.
      • Tabibnejad N.
      Follow up of infertile patients after failed ART cycles: a preliminary report from Iran and Turkey.
      Iran, TurkeyCross-sectionalWomen who did not get pregnant after embryo transfer.329.02NoMultiple choiceStop ART.
      • Walschaerts M.
      • Bujan L.
      • Parinaud J.
      • Mieusset R.
      • Thonneau P.
      Treatment discontinuation in couples consulting for male infertility after failing to conceive.
      FranceRetrospective cohortCouples with male factor infertility.32NA4NAStructured interviewStop ART before getting pregnant.
      • Troude P.
      • Guibert J.
      • Bouyer J.
      • de La Rochebrochard E.
      Medical factors associated with early IVF discontinuation.
      FranceRetrospective cohortCouples undergoing the first cycle of IVF.333.01YesMultiple choiceInterrupt ART after the first cycle.
      • Domar A.D.
      • Rooney K.
      • Hacker M.R.
      • Sakkas D.
      • Dodge L.E.
      Burden of care is the primary reason why insured women terminate in vitro fertilization treatment.
      USACross-sectionalWomen aged 18–42 years at the time of discontinuation.354.51YesMultiple choiceDiscontinue ART for 1 year after the first cycle.
      • Miller L.M.
      • Wallace G.
      • Birdsall M.A.
      • Hammond E.R.
      • Peek J.C.
      Dropout rate and cumulative birth outcomes in couples undergoing in vitro fertilization within a funded and actively managed system of care in New Zealand.
      New ZealandRetrospective cohortCouples qualifying for publicly funded IVF treatment.323.41YesNone (only medical records)Interrupt ART after the first cycle.
      ART, assisted reproductive technology; IUI, intrauterine insemination; NA, information not available.
      In terms of data collection tools, one study used records from a previous survey to evaluate reasons for ART treatment discontinuation (
      • Troude P.
      • Guibert J.
      • Bouyer J.
      • de La Rochebrochard E.
      Medical factors associated with early IVF discontinuation.
      ), one retrieved information from medical records (
      • Miller L.M.
      • Wallace G.
      • Birdsall M.A.
      • Hammond E.R.
      • Peek J.C.
      Dropout rate and cumulative birth outcomes in couples undergoing in vitro fertilization within a funded and actively managed system of care in New Zealand.
      ), whereas the remaining 10 studies used prospective questionnaires completed by participants (email, telephone or interview methods). Ten studies used structured questionnaires (multiple choice of Likert-type scale), whereas two asked open questions (Table 1).

      Results summary

      As shown in Table 2, ‘stress’ or some proxy term was cited as a reason for ART discontinuation by 775 out of 2507 participants (pooled prevalence = 30.9, range 11–53%). In all included studies, stress evaluation was subjective and self-reported or based on the retrospective review of annotations in medical records. None of the studies used objective scales to measure stress symptoms or laboratory tests to quantify stress biomarkers (Table 2).
      TABLE 2MAIN RESULTS OF THE INCLUDED STUDIES
      Author, yearSelected participants, nParticipants with follow-up, nDiscontinuation rate, n (%)‘Stress’ as reason for discontinuation, n (%)Stress measure
      • Mao K.
      • Wood C.
      Barriers to treatment of infertility by in-vitro fertilization and embryo transfer.
      22891121/228 (53.1)32/91 (35.2)Response to questionnaire citing ‘disruption of life and strain on marriage’.
      • Goldfarb J.
      • Austin C.
      • Lisbona H.
      • Loret de Mola R.
      • Peskin B.
      • Stewart S.
      Factors influencing patients' decision not to repeat IVF.
      5428NA11/28 (39.3)Marking ‘agree’ in a Likert-type scale stating that dropout was due to emotional distress.
      • Rajkhowa M.
      • McConnell A.
      • Thomas G.E.
      Reasons for discontinuation of IVF treatment: a questionnaire study.
      1510732247/732 (33.7)185/513 (36.1)Response to questionnaire stating ‘psychological stress’ as a reason for discontinuation.
      • Brandes M.
      • van der Steen J.O.
      • Bokdam S.B.
      • Hamilton C.J.
      • de Bruin J.P.
      • Nelen W.L.
      • Kremer J.A.
      When and why do subfertile couples discontinue their fertility care? A longitudinal cohort study in a secondary care subfertility population.
      13911347319/1347 (23.7)71/319 (22.3)Self-reported ‘emotional distress’ in open-ended questionnaire.
      • Moini A.
      • Salehizadeh S.
      • Moosavi F.
      • Kiani K.
      • Khafri S.
      Discontinuation decision in assisted reproductive techniques.
      665338376/665 (56.5)169/338 (50.0)Self-reported ‘psychological stress’ as a reason for discontinuation.
      • Domar A.D.
      • Smith K.
      • Conboy L.
      • Iannone M.
      • Alper M.
      A prospective investigation into the reasons why insured United States patients drop out of in vitro fertilization treatment.
      390390133/390 (34.1)16/41 (39.0)Response to questionnaire listing ‘causes of treatment stress’.
      • McDowell S.
      • Murray A.
      Barriers to continuing in vitro fertilisation–why do patients exit fertility treatment?.
      131052681/526 (15.4)43/81 (53.1)Marking ‘agree’ or ‘strongly agree’ in a Likert-type scale for ‘stress’ as a reason for dropout.
      • Khalili M.A.
      • Kahraman S.
      • Ugur M.G.
      • Agha-Rahimi A.
      • Tabibnejad N.
      Follow up of infertile patients after failed ART cycles: a preliminary report from Iran and Turkey.
      621553139/553 (25.1)25/139 (18.0)Response to questionnaire stating ‘psychological stress’ as a reason for discontinuation.
      • Walschaerts M.
      • Bujan L.
      • Parinaud J.
      • Mieusset R.
      • Thonneau P.
      Treatment discontinuation in couples consulting for male infertility after failing to conceive.
      1345879407/879 (46.3)93/407 (22.9)Response to telephone interview stating ‘emotional painfulness of treatment’ as a reason for dropout.
      • Troude P.
      • Guibert J.
      • Bouyer J.
      • de La Rochebrochard E.
      Medical factors associated with early IVF discontinuation.
      650751351337/5135 (26.0)32/299 (10.7)Medical record stating ‘psychological burden of treatment’ as a reason for dropout.
      • Domar A.D.
      • Rooney K.
      • Hacker M.R.
      • Sakkas D.
      • Dodge L.E.
      Burden of care is the primary reason why insured women terminate in vitro fertilization treatment.
      893312204/312 (65.4)82/204 (40.2)Response to structured questionnaire stating that ‘further treatment was too stressful’.
      • Miller L.M.
      • Wallace G.
      • Birdsall M.A.
      • Hammond E.R.
      • Peek J.C.
      Dropout rate and cumulative birth outcomes in couples undergoing in vitro fertilization within a funded and actively managed system of care in New Zealand.
      35035047/350 (13.4)16/47 (34.0)Medical record stating ‘emotional stress’ as a reason for dropout.
      NA, information not available.
      In terms of the primary sources of stress during ART treatment, a structured questionnaire answered by 127 women from one IVF centre in the USA highlighted ‘infertility taking too much of a toll on our relationship’; ‘too anxious or depressed to continue’; ‘it was too difficult to get to the IVF centre so often’; ‘I had already given IVF my best chance’; and ‘could not stand the side-effects of medication’ (
      • Domar A.D.
      • Smith K.
      • Conboy L.
      • Iannone M.
      • Alper M.
      A prospective investigation into the reasons why insured United States patients drop out of in vitro fertilization treatment.
      ;
      • Domar A.D.
      • Rooney K.
      • Hacker M.R.
      • Sakkas D.
      • Dodge L.E.
      Burden of care is the primary reason why insured women terminate in vitro fertilization treatment.
      ). Clinical factors associated with worse ART prognosis, such as advanced age increased the fear of failing and were reported as important stressors (
      • Mao K.
      • Wood C.
      Barriers to treatment of infertility by in-vitro fertilization and embryo transfer.
      ;
      • Troude P.
      • Guibert J.
      • Bouyer J.
      • de La Rochebrochard E.
      Medical factors associated with early IVF discontinuation.
      ). Physical discomfort owing to treatment procedures was also mentioned as a stress factor (
      • Domar A.D.
      • Smith K.
      • Conboy L.
      • Iannone M.
      • Alper M.
      A prospective investigation into the reasons why insured United States patients drop out of in vitro fertilization treatment.
      ) and a contributing factor to dropout (
      • Goldfarb J.
      • Austin C.
      • Lisbona H.
      • Loret de Mola R.
      • Peskin B.
      • Stewart S.
      Factors influencing patients' decision not to repeat IVF.
      ;
      • Moini A.
      • Salehizadeh S.
      • Moosavi F.
      • Kiani K.
      • Khafri S.
      Discontinuation decision in assisted reproductive techniques.
      ;
      • Domar A.D.
      • Smith K.
      • Conboy L.
      • Iannone M.
      • Alper M.
      A prospective investigation into the reasons why insured United States patients drop out of in vitro fertilization treatment.
      ;
      • Troude P.
      • Guibert J.
      • Bouyer J.
      • de La Rochebrochard E.
      Medical factors associated with early IVF discontinuation.
      ). Family demands, time pressure and economic burden were also cited as potential stressors (
      • Mao K.
      • Wood C.
      Barriers to treatment of infertility by in-vitro fertilization and embryo transfer.
      ;
      • Rajkhowa M.
      • McConnell A.
      • Thomas G.E.
      Reasons for discontinuation of IVF treatment: a questionnaire study.
      ;
      • Brandes M.
      • van der Steen J.O.
      • Bokdam S.B.
      • Hamilton C.J.
      • de Bruin J.P.
      • Nelen W.L.
      • Kremer J.A.
      When and why do subfertile couples discontinue their fertility care? A longitudinal cohort study in a secondary care subfertility population.
      ;
      • Moini A.
      • Salehizadeh S.
      • Moosavi F.
      • Kiani K.
      • Khafri S.
      Discontinuation decision in assisted reproductive techniques.
      ;
      • Domar A.D.
      • Smith K.
      • Conboy L.
      • Iannone M.
      • Alper M.
      A prospective investigation into the reasons why insured United States patients drop out of in vitro fertilization treatment.
      ;
      • Khalili M.A.
      • Kahraman S.
      • Ugur M.G.
      • Agha-Rahimi A.
      • Tabibnejad N.
      Follow up of infertile patients after failed ART cycles: a preliminary report from Iran and Turkey.
      ;
      • Troude P.
      • Guibert J.
      • Bouyer J.
      • de La Rochebrochard E.
      Medical factors associated with early IVF discontinuation.
      ) (Figure 1).

      Quality assessment

      Newcastle–Ottawa Scale ratings indicated four studies (
      • Mao K.
      • Wood C.
      Barriers to treatment of infertility by in-vitro fertilization and embryo transfer.
      ;
      • Goldfarb J.
      • Austin C.
      • Lisbona H.
      • Loret de Mola R.
      • Peskin B.
      • Stewart S.
      Factors influencing patients' decision not to repeat IVF.
      ;
      • McDowell S.
      • Murray A.
      Barriers to continuing in vitro fertilisation–why do patients exit fertility treatment?.
      ;
      • Walschaerts M.
      • Bujan L.
      • Parinaud J.
      • Mieusset R.
      • Thonneau P.
      Treatment discontinuation in couples consulting for male infertility after failing to conceive.
      ) of fair quality and eight of good quality (
      • Rajkhowa M.
      • McConnell A.
      • Thomas G.E.
      Reasons for discontinuation of IVF treatment: a questionnaire study.
      ;
      • Brandes M.
      • van der Steen J.O.
      • Bokdam S.B.
      • Hamilton C.J.
      • de Bruin J.P.
      • Nelen W.L.
      • Kremer J.A.
      When and why do subfertile couples discontinue their fertility care? A longitudinal cohort study in a secondary care subfertility population.
      ;
      • Moini A.
      • Salehizadeh S.
      • Moosavi F.
      • Kiani K.
      • Khafri S.
      Discontinuation decision in assisted reproductive techniques.
      ;
      • Domar A.D.
      • Smith K.
      • Conboy L.
      • Iannone M.
      • Alper M.
      A prospective investigation into the reasons why insured United States patients drop out of in vitro fertilization treatment.
      ;
      • Khalili M.A.
      • Kahraman S.
      • Ugur M.G.
      • Agha-Rahimi A.
      • Tabibnejad N.
      Follow up of infertile patients after failed ART cycles: a preliminary report from Iran and Turkey.
      ;
      • Troude P.
      • Guibert J.
      • Bouyer J.
      • de La Rochebrochard E.
      Medical factors associated with early IVF discontinuation.
      ;
      • Domar A.D.
      • Rooney K.
      • Hacker M.R.
      • Sakkas D.
      • Dodge L.E.
      Burden of care is the primary reason why insured women terminate in vitro fertilization treatment.
      ;
      • Miller L.M.
      • Wallace G.
      • Birdsall M.A.
      • Hammond E.R.
      • Peek J.C.
      Dropout rate and cumulative birth outcomes in couples undergoing in vitro fertilization within a funded and actively managed system of care in New Zealand.
      ), according to scale conversion thresholds of Agency for Health Care Research and Quality standards (Supplementary Table). Consensus was reached on all occasions, and no study was excluded from this review based on the risk of bias.

      Discussion

      Main findings

      In this systematic review, we found that ‘stress’ was mentioned by a high proportion (>30%) of patients who terminated ART treatments, but quantifiable stress signs, symptoms and biomarkers were not assessed. Clinical factors associated with worse prognosis, physical discomfort caused by treatment procedures, family demands, time pressure and economic burden were identified as ‘stress’ factors arising during ART treatment. The included studies had different designs but most used structured questionnaires, whereas two applied open questionnaires in which patients spontaneously reported their reasons behind ART discontinuation.

      Interpretation

      Woman's age, together with the number of recovered oocytes and the number of viable embryos for transfer, are determining elements of the success or failure of the treatment (
      • Leijdekkers J.A.
      • Eijkemans M.J.C.
      • van Tilborg T.C.
      • Oudshoorn S.C.
      • van Golde R.J.T.
      • Hoek A.
      • Lambalk C.B.
      • de Bruin J.P.
      • Fleischer K.
      • Mochtar M.H.
      • Kuchenbecker W.K.H.
      • Laven J.S.E.
      • Mol B.W.J.
      • Torrance H.L.
      • Broekmans F.J.M.
      Cumulative live birth rates in low-prognosis women.
      ). In this context, advanced age per se is a source of stress in these patients, which is aggravated in those with diminished ovarian reserve. Fertility preservation through oocyte vitrification is an alternative to ‘stop the clock’ and reduce time pressure on patients who need to postpone gestation. Female fertility preservation, however, still requires complex, expensive, and sometimes painful procedures, which can be stressful.
      Couples with fertility problems may experience a state of mental suffering derived from the uncertainties and demands that come with the clinical condition and treatments (
      • González-Rodríguez A.
      • Cobo J.
      • Soria V.
      • Usall J.
      • Garcia-Rizo C.
      • Bioque M.
      • Monreal J.A.
      • Labad J.
      Women Undergoing Hormonal Treatments for Infertility: A Systematic Review on Psychopathology and Newly Diagnosed Mood and Psychotic Disorders.
      ). Psychological suffering varies according to personal beliefs and social pressure to become parents (
      • Dancet E.A.
      • Van Empel I.W.
      • Rober P.
      • Nelen W.L.
      • Kremer J.A.
      • D'Hooghe T.M.
      Patient-centred infertility care: a qualitative study to listen to the patient's voice.
      ). Facing childlessness can be traumatic and challenging, particularly when dealing with feedback from family and friends.
      The final decision to terminate treatment may be driven by unrealistic expectations of success and the inability to deal with treatment failure. Many couples enter treatment confidently but end up succumbing to despair after repeated unsuccessful IVF cycles. The realization that live birth rates are typically below 50% per ART cycle, added to the high cost of treatment, contributes to further increase the psychological stress of patients (
      • McDowell S.
      • Murray A.
      Barriers to continuing in vitro fertilisation–why do patients exit fertility treatment?.
      ;
      • Custers I.M.
      • van Dessel T.H.
      • Flierman P.A.
      • Steures P.
      • van Wely M.
      • van der Veen F.
      • Mol B.W.
      Couples dropping out of a reimbursed intrauterine insemination program: what is their prognostic profile and why do they drop out?.
      ;
      • Troude P.
      • Guibert J.
      • Bouyer J.
      • de La Rochebrochard E.
      Medical factors associated with early IVF discontinuation.
      ;
      • Domar A.D.
      • Rooney K.
      • Hacker M.R.
      • Sakkas D.
      • Dodge L.E.
      Burden of care is the primary reason why insured women terminate in vitro fertilization treatment.
      ). Financial cost is a relevant stress factor for many individuals because, in many health systems of different countries, ART treatments are not insured (
      • Rooney K.L.
      • Domar A.D.
      The relationship between stress and infertility.
      ;
      • Oliveira B.L.
      • Ataman L.M.
      • Rodrigues J.K.
      • Birchal T.S.
      • Reis F.M.
      Restricted access to assisted reproductive technology and fertility preservation: legal and ethical issues.
      ).

      Strengths and limitations

      A strength of the present systematic review is that the studies evaluated were fairly homogeneous in objectives, inclusion criteria, discontinuity definitions, data collection tools and outcomes. The overall response rate in studies was high, which provided a broad dataset for analysis. The main limitation of our systematic review is the lack of studies with a robust method to assess and quantify the stress experienced by the participants. Notably, none of the studies evaluated the stress response with objective scales or biomarkers, and all relied on what the participants themselves perceived as ‘emotional stress’. The selected studies, although identifying probable associations between stress and ART discontinuation, did not evaluate if stress reduction interventions decreased ART discontinuation rates.

      Conclusion and perspectives

      In summary, about one-third of the individuals who decide to discontinue ART treatments attribute their decision to the ‘stress’ associated with treatment failure (or the fear of failing), physical discomfort, family pressure, time constrains and economic burden. As some of these factors cannot be avoided, psychological support may help infertile couples cope with stress and mitigate their psychological suffering (
      • Domar A.D.
      • Gross J.
      • Rooney K.
      • Boivin J.
      Exploratory randomized trial on the effect of a brief psychological intervention on emotions, quality of life, discontinuation, and pregnancy rates in in vitro fertilization patients.
      ). Patients should be well informed, given the opportunity to discuss treatment concerns, and receive guidance on possible negative outcomes. New randomized controlled trials should investigate whether stress-reducing interventions might prevent early dropouts, thereby improving cumulative live birth rates in ART treatments.

      Data availability

      Data will be made available on request.

      Appendix. Supplementary materials

      References

        • Brandes M.
        • van der Steen J.O.
        • Bokdam S.B.
        • Hamilton C.J.
        • de Bruin J.P.
        • Nelen W.L.
        • Kremer J.A.
        When and why do subfertile couples discontinue their fertility care? A longitudinal cohort study in a secondary care subfertility population.
        Hum. Reprod. 2009; 24: 3127-3135
        • Chambers G.M.
        • Dyer S.
        • Zegers-Hochschild F.
        • de Mouzon J.
        • Ishihara O.
        • Banker M.
        • Mansour R.
        • Kupka M.S.
        • Adamson G.D.
        International Committee for Monitoring Assisted Reproductive Technologies world report: assisted reproductive technology, 2014dagger.
        Hum. Reprod. 2021; 36: 2921-2934
        • Cox C.M.
        • Thoma M.E.
        • Tchangalova N.
        • Mburu G.
        • Bornstein M.J.
        • Johnson C.L.
        • Kiarie J.
        Infertility prevalence and the methods of estimation from 1990 to 2021: a systematic review and meta-analysis.
        Hum. Reprod. Open. 2022; (2022): hoac051
        • Custers I.M.
        • van Dessel T.H.
        • Flierman P.A.
        • Steures P.
        • van Wely M.
        • van der Veen F.
        • Mol B.W.
        Couples dropping out of a reimbursed intrauterine insemination program: what is their prognostic profile and why do they drop out?.
        Fertil. Steril. 2013; 99: 1294-1298
        • Dancet E.A.
        • Van Empel I.W.
        • Rober P.
        • Nelen W.L.
        • Kremer J.A.
        • D'Hooghe T.M.
        Patient-centred infertility care: a qualitative study to listen to the patient's voice.
        Hum. Reprod. 2011; 26: 827-833
        • Domar A.D.
        • Gross J.
        • Rooney K.
        • Boivin J.
        Exploratory randomized trial on the effect of a brief psychological intervention on emotions, quality of life, discontinuation, and pregnancy rates in in vitro fertilization patients.
        Fertil. Steril. 2015; 104 (440-451 e447)
        • Domar A.D.
        • Rooney K.
        • Hacker M.R.
        • Sakkas D.
        • Dodge L.E.
        Burden of care is the primary reason why insured women terminate in vitro fertilization treatment.
        Fertil. Steril. 2018; 109: 1121-1126
        • Domar A.D.
        • Smith K.
        • Conboy L.
        • Iannone M.
        • Alper M.
        A prospective investigation into the reasons why insured United States patients drop out of in vitro fertilization treatment.
        Fertil. Steril. 2010; 94: 1457-1459
        • Galhardo A.
        • Alves J.
        • Moura-Ramos M.
        • Cunha M.
        Infertility-related stress and depressive symptoms - the role of experiential avoidance: a cross-sectional study.
        J. Reprod. Infant. Psychol. 2020; 38: 139-150
        • Geisler M.
        • Meaney S.
        • Waterstone J.
        • O'Donoghue K.
        Stress and the impact on the outcome of medically assisted reproduction.
        Eur. J. Obstet. Gynecol. Reprod. Biol. 2020; 248: 187-192
        • Goldfarb J.
        • Austin C.
        • Lisbona H.
        • Loret de Mola R.
        • Peskin B.
        • Stewart S.
        Factors influencing patients' decision not to repeat IVF.
        J. Assist. Reprod. Genet. 1997; 14: 381-384
        • González-Rodríguez A.
        • Cobo J.
        • Soria V.
        • Usall J.
        • Garcia-Rizo C.
        • Bioque M.
        • Monreal J.A.
        • Labad J.
        Women Undergoing Hormonal Treatments for Infertility: A Systematic Review on Psychopathology and Newly Diagnosed Mood and Psychotic Disorders.
        Front Psychiatry. 2020; 11: 479
        • Gu F.
        • Ruan S.
        • Luo C.
        • Huang Y.
        • Luo L.
        • Xu Y.
        • Zhou C.
        Can repeat IVF/ICSI cycles compensate for the natural decline in fertility with age? an estimate of cumulative live birth rates over multiple IVF/ICSI cycles in Chinese advanced-aged population.
        Aging (Albany NY). 2021; 13: 14385-14398
        • Khalili M.A.
        • Kahraman S.
        • Ugur M.G.
        • Agha-Rahimi A.
        • Tabibnejad N.
        Follow up of infertile patients after failed ART cycles: a preliminary report from Iran and Turkey.
        Eur. J. Obstet. Gynecol. Reprod. Biol. 2012; 161: 38-41
        • Lande Y.
        • Seidman D.S.
        • Maman E.
        • Baum M.
        • Hourvitz A.
        Why do couples discontinue unlimited free IVF treatments?.
        Gynecol Endocrinol. 2015; 31: 233-236
        • Lazarus R.
        • Folkman S.
        Stress, appraisal, and coping.
        Springer Publishing Company, 1984
        • Leijdekkers J.A.
        • Eijkemans M.J.C.
        • van Tilborg T.C.
        • Oudshoorn S.C.
        • van Golde R.J.T.
        • Hoek A.
        • Lambalk C.B.
        • de Bruin J.P.
        • Fleischer K.
        • Mochtar M.H.
        • Kuchenbecker W.K.H.
        • Laven J.S.E.
        • Mol B.W.J.
        • Torrance H.L.
        • Broekmans F.J.M.
        Cumulative live birth rates in low-prognosis women.
        Hum. Reprod. 2019; 34: 1030-1041
        • Lindeberg S.I.
        • Ostergren P.O.
        • Lindbladh E.
        Exhaustion is differentiable from depression and anxiety: evidence provided by the SF-36 vitality scale.
        Stress. 2006; 9: 117-123
        • Mao K.
        • Wood C.
        Barriers to treatment of infertility by in-vitro fertilization and embryo transfer.
        Med. J. Aust. 1984; 140: 532-533
        • McDowell S.
        • Murray A.
        Barriers to continuing in vitro fertilisation–why do patients exit fertility treatment?.
        Aust. N. Z. J. Obstet. Gynaecol. 2011; 51: 84-90
        • Miller L.M.
        • Wallace G.
        • Birdsall M.A.
        • Hammond E.R.
        • Peek J.C.
        Dropout rate and cumulative birth outcomes in couples undergoing in vitro fertilization within a funded and actively managed system of care in New Zealand.
        Fertil. Steril. 2021; 116: 114-122
        • Moini A.
        • Salehizadeh S.
        • Moosavi F.
        • Kiani K.
        • Khafri S.
        Discontinuation decision in assisted reproductive techniques.
        International Journal of Fertility and Sterility. 2009; 4: 173-178
        • Nery S.F.
        • Paiva S.P.C.
        • Vieira É L.
        • Barbosa A.B.
        • Sant'Anna E.M.
        • Casalechi M.
        • Dela Cruz C.
        • Teixeira A.L.
        • Reis F.M.
        Mindfulness-based program for stress reduction in infertile women: Randomized controlled trial.
        Stress Health. 2019; 35: 49-58
        • Oliveira B.L.
        • Ataman L.M.
        • Rodrigues J.K.
        • Birchal T.S.
        • Reis F.M.
        Restricted access to assisted reproductive technology and fertility preservation: legal and ethical issues.
        Reprod Biomed Online. 2021; 43: 571-576
        • Page M.J.
        • McKenzie J.E.
        • Bossuyt P.M.
        • Boutron I.
        • Hoffmann T.C.
        • Mulrow C.D.
        • Shamseer L.
        • Tetzlaff J.M.
        • Akl E.A.
        • Brennan S.E.
        • Chou R.
        • Glanville J.
        • Grimshaw J.M.
        • Hrobjartsson A.
        • Lalu M.M.
        • Li T.
        • Loder E.W.
        • Mayo-Wilson E.
        • McDonald S.
        • McGuinness L.A.
        • Stewart L.A.
        • Thomas J.
        • Tricco A.C.
        • Welch V.A.
        • Whiting P.
        • Moher D.
        The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
        BMJ. 2021; 372: n71
        • Rahimi R.
        • Hasanpour S.
        • Mirghafourvand M.
        • Esmaeilpour K.
        Effect of Hope-oriented group counseling on mental health of infertile women with failed IVF cycles: a randomized controlled trial.
        BMC Psychiatry. 2021; 21: 286
        • Rajkhowa M.
        • McConnell A.
        • Thomas G.E.
        Reasons for discontinuation of IVF treatment: a questionnaire study.
        Hum Reprod. 2006; 21: 358-363
        • Reis F.M.
        • Coutinho L.M.
        • Vannuccini S.
        • Luisi S.
        • Petraglia F.
        Is Stress a Cause or a Consequence of Endometriosis?.
        Reprod. Sci. 2020; 27: 39-45
        • Rooney K.L.
        • Domar A.D.
        The relationship between stress and infertility.
        Dialogues Clin Neurosci. 2018; 20: 41-47
        • Sant'Anna E.M.
        • Paiva S.P.C.
        • Santos R.P.
        • Rodrigues A.M.S.
        • Davis N.A.
        • Nery S.F.
        • Maia F.P.
        • Ferreira A.V.M.
        • Reis F.M.
        Mindfulness-based program to support lifestyle modification and weight loss in infertile women: randomized controlled trial.
        J. Psychosom. Obstet. Gynaecol. 2020; : 1-9
        • Schröder A.K.
        • Katalinic A.
        • Diedrich K.
        • Ludwig M.
        Cumulative pregnancy rates and drop-out rates in a German IVF programme: 4102 cycles in 2130 patients.
        Reprod. Biomed Online. 2004; 8: 600-606
        • Selye H.
        A syndrome produced by diverse nocuous agents. 1936.
        J. Neuropsychiatry Clin. Neurosci. 1998; 10: 230-231
        • Shamsrizi P.
        • Gladstone B.P.
        • Carrara E.
        • Luise D.
        • Cona A.
        • Bovo C.
        • Tacconelli E.
        Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis.
        BMJ Open. 2020; 10e030266
        • Smeenk J.M.
        • Verhaak C.M.
        • Stolwijk A.M.
        • Kremer J.A.
        • Braat D.D.
        Reasons for dropout in an in vitro fertilization/intracytoplasmic sperm injection program.
        Fertil. Steril. 2004; 81: 262-268
        • Stefanaki C.
        • Pervanidou P.
        • Boschiero D.
        • Chrousos G.P.
        Chronic stress and body composition disorders: implications for health and disease.
        Hormones (Athens). 2018; 17: 33-43
        • Troude P.
        • Guibert J.
        • Bouyer J.
        • de La Rochebrochard E.
        Medical factors associated with early IVF discontinuation.
        Reprod Biomed Online. 2014; 28: 321-329
        • Tsigos C.
        • Kyrou I.
        • Kassi E.
        • Chrousos G.P.
        Stress: Endocrine Physiology and Pathophysiology.
        in: Feingold KR Anawalt B Boyce A Chrousos G De Herder WW Dhatariya K Dungan K Hershman JM Hofland J Kalra S Kaltsas G Koch C Kopp P Korbonits M Kovacs CS Kuohung W Laferrere B Levy M Mcgee EA Mclachlan R Morley JE New M Purnell J Sahay R Singer F Sperling MA Stratakis CA Trence DL Wilson DP Endotext. 2000
        • Verkuijlen J.
        • Verhaak C.
        • Nelen W.L.
        • Wilkinson J.
        • Farquhar C.
        Psychological and educational interventions for subfertile men and women.
        Cochrane Database Syst Rev. 2016; 3Cd011034
        • Walschaerts M.
        • Bujan L.
        • Parinaud J.
        • Mieusset R.
        • Thonneau P.
        Treatment discontinuation in couples consulting for male infertility after failing to conceive.
        Fertil. Steril. 2013; 99: 1319-1323

      Biography

      Fernando M Reis is Professor of Gynaecology and Reproductive Medicine at Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, and has been Visiting Professor at the universities of Siena and Paris. His research background includes reproductive physiology, stress response and infertility.
      Key message
      Clinical factors associated with worse prognosis, physical discomfort caused by treatment procedures, family demands, time pressure and economic burden were identified as sources of ‘stress’ that contributed to assisted reproductive technology discontinuation.